AVEO Oncology
AVEO
#7012
Rank
C$0.71 B
Marketcap
C$20.58
Share price
0.00%
Change (1 day)
159.82%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$73.2 Million a decrease over its 2020 earnings that were of -C$48.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-49.17%
2021 -C$73.2 Million49.9%
2020 -C$48.83 Million-479.04%
2019 C$12.88 M-276.17%
2018 -C$7.32 Million-91.79%
2017 -C$89.09 Million142.38%
2016 -C$36.76 Million78.51%
2015 -C$20.59 Million-71.55%
2014 -C$72.37 Million-50.72%
2013 -C$0.15 Billion-4.88%
2012 -C$0.16 Billion-426.29%
2011 C$47.31 M-159.85%
2010 -C$79.07 Million35.33%
2009 -C$58.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$30.87 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.31 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.61 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.17 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$11.02 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.1 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA